Kratium (Diazepam)

Diazepam binds to the benzodiazepine site on the GABA‑A receptor complex, enhancing GABA’s inhibitory effect. This increases chloride ion flow into neurons, hyperpolarising them and decreasing neuronal excitability, which produces anxiolytic, anticonvulsant, muscle‑relaxant and sedative effects.

The appropriate dose of Kratium is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal and hepatic function, and any concomitant medications. Dosage regimens are not standardized and should follow the prescriber’s instructions.

Safety data for diazepam in pregnancy and lactation are limited. It is classified as a potential risk to the fetus and infant, and use should only occur when the benefit justifies the potential harm. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To order Kratium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Kratium (diazepam) shares the core pharmacologic profile of benzodiazepines—enhancing GABA activity—but differs in its relatively long half‑life and active metabolites, which can provide smoother symptom control but may increase accumulation in the elderly. Compared with shorter‑acting agents like lorazepam, diazepam may require less frequent dosing but carries a higher potential for prolonged sedation.

Kratium should be stored at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Kratium is administered orally. The tablet should be swallowed whole with a glass of water and taken exactly as prescribed. It is not intended for crushing, chewing, or sublingual use unless specifically directed by a healthcare professional.

Serious risks include respiratory depression, especially when combined with other central nervous system depressants; severe hypotension; paradoxical reactions such as aggression or agitation; dependence and withdrawal syndrome after prolonged use; hepatic dysfunction; and rare severe skin reactions like Stevens‑Johnson syndrome. Immediate medical attention is required if any of these occur.

Kratium is contraindicated in patients with known hypersensitivity to diazepam or any benzodiazepine, those with acute narrow‑angle glaucoma, and individuals with severe respiratory insufficiency. Caution is also advised for patients with a history of substance misuse, severe hepatic impairment, or those taking interacting medications that could precipitate excessive sedation.